Get started
Author

M. Alonso

Observed name: M Alonso
ORCID: 0009-0002-3442-8921
Observed ORCID: 0009-0002-3442-8921
OpenAlex ID: A5040327732
SEOM clinical guidelines for anaplastic gliomas (2017)
2017 · C. Balañá, M. Alonso, et al. · Clinical & Translational Oncology · 15
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma
2023 · L. Gately, C. Mesía, et al. · Journal of Neuro-Oncology · 5
454P Tetrahydrocannabinol (THC) / cannabidiol (CBD) oral solution in combination with temozolomide (TMZ) and radiotherapy (RT) in patients with newly diagnosed glioblastoma: Phase Ib GEINO-1601 trial
2024 · J.M. Sepúlveda, M. Alonso, et al. · Annals of Oncology · 3
Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma
2024 · L. Gately, C. Mesía, et al. · Journal of Neuro-Oncology · 3
PDF
Correction to: SEOM clinical guidelines for anaplastic gliomas (2017)
2018 · C. Balañá, M. Alonso, et al. · Clinical & Translational Oncology · 3
PDF
Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)
2024 · Lucy Gately, C. Mesía, et al. · Journal of Neuro-Oncology · 2
501O Glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial
2023 · M.Á. Vaz, S. del Barco, et al. · Annals of Oncology · 1
PDF
P2.04-24 Nivolumab in the "Real World": Are the Results of Clinical Trials Reproducible?
2018 · I. Ramos García, A. Sanchez Gastaldo, et al. · Journal of Thoracic Oncology · 1
PDF
451MO Final results of glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial
2024 · M.A. Vaz Salgado, S. del Barco, et al. · Annals of Oncology
PDF
Exploring the management of elderly patients with glioblastoma using data from GEINO14-01 and EX-TEM
2023 · L. Gately, C. Mesia, et al. · Journal of Geriatric Oncology
Spanish survey of treatment recommendations for elderly patients with glioblastoma
2019 · M Á Vaz Salgado, Á Rodríguez Sánchez, et al. · Annals of Oncology
Extending temozolomide longer than six cycles in glioblastoma: Results of the randomized GEINO-014 trial
2019 · M.A.V. Salgado, J.M. Sepulveda Sanchez, et al. · Annals of Oncology
PDF
P14.58 Extending adjuvant temozolomide longer than six cycles doesn’t add any benefit to glioblastoma patients according to the randomized GEINO-014 TRIAL
2019 · C Balana, J Sepulveda, et al. · Neuro-Oncology
A phase lllb, open.label study of afatinib in EGFR TKI-naive patients with EGFR mutation-positive NSCLC: A biomarker analysis
2019 · Rasmus Rössel, M. Poltoratskiy, et al.
Works count: 14
Citation count: 33
H-index: 3
I10-index: 1
Year
Topic
Type